D Banerjee

669 total citations
14 papers, 555 citations indexed

About

D Banerjee is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, D Banerjee has authored 14 papers receiving a total of 555 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Genetics. Recurrent topics in D Banerjee's work include Virus-based gene therapy research (5 papers), Acute Lymphoblastic Leukemia research (3 papers) and Cancer-related Molecular Pathways (3 papers). D Banerjee is often cited by papers focused on Virus-based gene therapy research (5 papers), Acute Lymphoblastic Leukemia research (3 papers) and Cancer-related Molecular Pathways (3 papers). D Banerjee collaborates with scholars based in United States, United Kingdom and Canada. D Banerjee's co-authors include Shin Mineishi, Joseph R. Bertino, Eli Gilboa, Michael Flaßhove, Moore Ma, Barry Schweitzer, Daniel Hochhauser, Geoffrey M. Wahl, Alexandru Almasan and Ronan M. Kelly and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

D Banerjee

14 papers receiving 542 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D Banerjee United States	10	348	186	172	85	85	14	555
Lori Jerome Canada	11	739 2.1×	174 0.9×	134 0.8×	35 0.4×	248 2.9×	18	979
Marja van Meijer Netherlands	13	453 1.3×	223 1.2×	232 1.3×	25 0.3×	290 3.4×	18	919
Zhilan Zeng United States	8	306 0.9×	127 0.7×	129 0.8×	20 0.2×	16 0.2×	10	508
Adam Cisterne Australia	9	225 0.6×	137 0.7×	45 0.3×	104 1.2×	233 2.7×	14	571
Irene Ni United States	11	347 1.0×	166 0.9×	69 0.4×	21 0.2×	43 0.5×	15	743
Sumiko Nakai Japan	8	421 1.2×	48 0.3×	121 0.7×	27 0.3×	74 0.9×	9	701
Martin Lodén Netherlands	11	328 0.9×	190 1.0×	71 0.4×	11 0.1×	84 1.0×	14	627
Xiangang Zou United Kingdom	17	422 1.2×	52 0.3×	176 1.0×	86 1.0×	30 0.4×	27	613
Nancy Pech United States	15	299 0.9×	217 1.2×	278 1.6×	11 0.1×	143 1.7×	26	764
Melodie A. Henderson United States	10	275 0.8×	63 0.3×	75 0.4×	24 0.3×	25 0.3×	13	529

Countries citing papers authored by D Banerjee

Since Specialization

Citations

This map shows the geographic impact of D Banerjee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Banerjee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Banerjee more than expected).

Fields of papers citing papers by D Banerjee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Banerjee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Banerjee. The network helps show where D Banerjee may publish in the future.

Co-authorship network of co-authors of D Banerjee

This figure shows the co-authorship network connecting the top 25 collaborators of D Banerjee. A scholar is included among the top collaborators of D Banerjee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D Banerjee. D Banerjee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

1.

Banerjee, D, et al.. (2024). P255 Cost-effectiveness analysis of vonoprazan versus lansoprazole in the medical management of erosive oesophagitis. Poster presentations. A200.2–A201. 1 indexed citations

2.

Banerjee, D, et al.. (2002). Potential of the proteasomal inhibitor MG-132 as an anticancer agent, alone and in combination.. PubMed. 21(6A). 3941–7. 25 indexed citations

3.

Banerjee, D. (2001). Genasense (Genta Inc).. PubMed. 2(4). 574–80. 44 indexed citations

4.

Banerjee, D, Youzhi Tong, Emine A. Ercikan-Abali, et al.. (1999). Protection of Bone Marrow Cells from Toxicity of Chemotherapeutic Agents Targeted toward Thymidylate Synthase by Transfer of Mutant Forms of Human Thymidylate Synthase cDNA. PubMed. 36. 107–114. 3 indexed citations

5.

Bertino, Joseph R., et al.. (1999). Use of Variants of Dihydrofolate Reductase in Gene Transfer to Produce Resistance to Methotrexate and Trimetrexate. PubMed. 36. 82–94. 3 indexed citations

6.

Bray, Mark R., Bruce Patterson, Laszlo Radvanyi, et al.. (1999). Shiga-like toxin-1 receptor on human breast cancer, lymphoma, and myeloma and absence from CD34(+) hematopoietic stem cells: implications for ex vivo tumor purging and autologous stem cell transplantation.. Blood. 94(8). 2901–10. 78 indexed citations

7.

Flaßhove, Michael, et al.. (1995). Ex vivo expansion and selection of human CD34+ peripheral blood progenitor cells after introduction of a mutated dihydrofolate reductase cDNA via retroviral gene transfer. Blood. 85(2). 566–574. 89 indexed citations

8.

Banerjee, D, Emine A. Ercikan-Abali, Mark Waltham, et al.. (1995). Molecular mechanisms of resistance to antifolates, a review.. Acta Biochimica Polonica. 42(4). 457–464. 36 indexed citations

9.

Li, W, Junyu Fan, Daniel Hochhauser, et al.. (1995). Lack of functional retinoblastoma protein mediates increased resistance to antimetabolites in human sarcoma cell lines.. Proceedings of the National Academy of Sciences. 92(22). 10436–10440. 91 indexed citations

10.

Flaßhove, Michael, et al.. (1995). Ex vivo expansion and selection of human CD34+ peripheral blood progenitor cells after introduction of a mutated dihydrofolate reductase cDNA via retroviral gene transfer. Blood. 85(2). 566–574. 3 indexed citations

11.

Banerjee, D, et al.. (1994). Development of a retroviral construct containing a human mutated dihydrofolate reductase cDNA for hematopoietic stem cell transduction. Blood. 83(11). 3403–3408. 52 indexed citations

12.

Banerjee, D, et al.. (1994). Development of a retroviral construct containing a human mutated dihydrofolate reductase cDNA for hematopoietic stem cell transduction. Blood. 83(11). 3403–3408. 39 indexed citations

13.

Hantzopoulos, Petros, et al.. (1992). Comparison of the Expression of a Mutant Dihydrofolate Reductase under Control of Different Internal Promoters in Retroviral Vectors. Human Gene Therapy. 3(4). 381–390. 52 indexed citations

14.

Dicker, Adam P., Matthias Volkenandt, Barry Schweitzer, D Banerjee, & Joseph R. Bertino. (1990). Identification and characterization of a mutation in the dihydrofolate reductase gene from the methotrexate-resistant Chinese hamster ovary cell line Pro-3 MtxRIII.. Journal of Biological Chemistry. 265(14). 8317–8321. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact